WINTON GROUP Ltd Sells 3,302 Shares of Masimo Co. (NASDAQ:MASI)

WINTON GROUP Ltd lowered its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 42.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 4,410 shares of the medical equipment provider's stock after selling 3,302 shares during the period. WINTON GROUP Ltd's holdings in Masimo were worth $729,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC lifted its position in shares of Masimo by 31.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 250 shares of the medical equipment provider's stock worth $42,000 after buying an additional 60 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Masimo by 40.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 64 shares during the last quarter. Blue Trust Inc. increased its position in Masimo by 56.3% during the 4th quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock worth $33,000 after purchasing an additional 71 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Masimo by 0.8% during the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,815 shares of the medical equipment provider's stock worth $1,622,000 after buying an additional 82 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in Masimo by 0.8% in the fourth quarter. Thrivent Financial for Lutherans now owns 10,456 shares of the medical equipment provider's stock valued at $1,728,000 after purchasing an additional 83 shares during the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several equities analysts recently commented on the company. Wells Fargo & Company upped their target price on Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Piper Sandler upped their price target on shares of Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research report on Wednesday, February 26th. Finally, Raymond James increased their target price on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research note on Friday, December 27th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $194.80.

Masimo Stock Up 0.6 %

Shares of NASDAQ MASI traded up $1.01 during mid-day trading on Tuesday, reaching $167.61. The company had a trading volume of 373,879 shares, compared to its average volume of 638,636. The stock has a market capitalization of $9.06 billion, a PE ratio of 115.59 and a beta of 1.04. The stock's 50 day moving average is $174.67 and its 200-day moving average is $162.10. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.38. The company had revenue of $600.70 million during the quarter, compared to analysts' expectations of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. As a group, equities analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Craig B. Reynolds sold 2,053 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the sale, the director now directly owns 16,581 shares in the company, valued at $2,754,601.53. The trade was a 11.02 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the transaction, the chief operating officer now owns 24,172 shares of the company's stock, valued at $4,048,568.28. The trade was a 55.38 % decrease in their position. The disclosure for this sale can be found here. Insiders own 9.70% of the company's stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.